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The goal of this study is the selective oxyfunctionalization of steroids under mild and environmentally friendly conditions using
fungal enzymes. With this purpose, peroxygenases from three basidiomycete species were tested for the hydroxylation of a vari-
ety of steroidal compounds, using H2O2 as the only cosubstrate. Two of them are wild-type enzymes from Agrocybe aegerita and
Marasmius rotula, and the third one is a recombinant enzyme from Coprinopsis cinerea. The enzymatic reactions on free and
esterified sterols, steroid hydrocarbons, and ketones were monitored by gas chromatography, and the products were identified
by mass spectrometry. Hydroxylation at the side chain over the steroidal rings was preferred, with the 25-hydroxyderivatives
predominating. Interestingly, antiviral and other biological activities of 25-hydroxycholesterol have been reported recently (M.
Blanc et al., Immunity 38:106–118, 2013, http://dx.doi.org/10.1016/j.immuni.2012.11.004). However, hydroxylation in the ring
moiety and terminal hydroxylation at the side chain also was observed in some steroids, the former favored by the absence of
oxygenated groups at C-3 and by the presence of conjugated double bonds in the rings. To understand the yield and selectivity
differences between the different steroids, a computational study was performed using Protein Energy Landscape Exploration
(PELE) software for dynamic ligand diffusion. These simulations showed that the active-site geometry and hydrophobicity fa-
vors the entrance of the steroid side chain, while the entrance of the ring is energetically penalized. Also, a direct correlation be-
tween the conversion rate and the side chain entrance ratio could be established that explains the various reaction yields
observed.
Steroids represent an important class of natural compoundsthat are widespread in nature and have a multitude of phar-
macological properties. Indeed, steroids are ranked among the
most marketedmedical products and represent the second largest
category next to antibiotics. The physiological activity of steroids
depends on their structures, including the oxidation state of the
rings, and the type, number, and regio- and stereoposition of the
functional groups attached (1). It is known that even minor
changes in the structure of steroids can highly affect their biolog-
ical activity, which has promoted countless studies on the modi-
fication of naturally occurring steroids in search of new andmore
active compounds (2). Among thesemodifications, hydroxylation
is one of the most important reactions in steroid oxyfunctional-
ization.
Hydroxylation serves to increase the polarity of the rather hy-
drophobic steroids, and hydroxylated steroids often express a
higher level of biological activity than their less polar nonhydroxy-
lated analogs. Moreover, hydroxylation can be used to develop
intermediates for further synthesis by offering access to otherwise
inaccessible sites of the steroid molecule. These modifications
have been obtained mostly by applying microorganisms (1), with
only a few examples where isolated enzymes were used. Members
of the cytochrome P450 monooxygenase (P450) superfamily are
notable examples of such enzymatic catalysts, since, because of
their catalytic versatility, they would perfectly meet the require-
ments of chemical synthesis (3, 4). However, large-scale applica-
tions are not yet feasible due to the intrinsic properties of these
oxygenases (5), whose activation requires NAD(P)H as an elec-
tron donor and auxiliary flavin-reductases (or a second flavin do-
main) for electron transfer to O2 (6).
A few years ago, a new peroxidase type was discovered in the
wood-dwelling basidiomyceteAgrocybe aegerita (7), which turned
out to be a true peroxygenase efficiently transferring oxygen from
peroxide to various organic substrates (8). This peroxygenase is
able to catalyze reactions formerly assigned only to P450s (9).
However, unlike P450s, which are intracellular enzymes whose
activation often requires an auxiliary enzyme and a source of re-
ducing power, the A. aegerita enzyme is a secreted protein; there-
fore, it is farmore stable and requires onlyH2O2 for activation (8).
The A. aegerita peroxygenase has been shown to catalyze numer-
ous interesting oxygenation reactions on aromatic compounds
(10), and recently, the action of this enzyme on aliphatic com-
pounds was demonstrated, expanding its biotechnological inter-
est (11, 12). The enzyme, first described as a haloperoxidase and
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later mostly referred to as aromatic peroxygenase (APO), now is
named “unspecific peroxygenase” (UPO; EC 1.11.2.1).
After the first peroxygenase of A. aegerita (7), similar enzymes
also have been found in other basidiomycetes, such as Coprinellus
radians (13) andMarasmius rotula (14), and there are indications
for their widespread occurrence in the fungal kingdom (15). Re-
cently, over 100 peroxygenase-type genes (encoding enzymes of
the heme-thiolate peroxidase superfamily) have been identified
during the analysis of 24 basidiomycete genomes (16), including
Coprinopsis cinerea (17). The wild-type C. cinerea peroxygenase
has not been isolated to date from this fungus, but one of the
peroxygenase genes from its genome (protein model 7249, avail-
able from the Joint Genome Institute [JGI; http://genome.jgi.doe
.gov/Copci1]) was heterologously expressed by Novozymes A/S
(Bagsvaerd, Denmark). This first recombinant peroxygenase can
be a powerful biocatalyst for synthetic applications because of the
potentially high expression yield and the possibility of tuning its
catalytic and operational properties using protein engineering
tools. Recently, the ability of this recombinant peroxygenase in the
oxyfunctionalization of several aliphatic compounds was demon-
strated (18).
Here, the efficiency of three different peroxygenases, namely,
the wild enzymes from A. aegerita (AaeUPO) and M. rotula
(MroUPO) and the recombinant enzyme from C. cinerea
(rCciUPO), in oxyfunctionalization of a variety of steroidal com-
pounds (including free and esterified sterols, steroid hydrocar-
bons, and ketones) is evaluated for the first time. All three fungi
are agaric basidiomycetes, but they belong to different families of
the order Agaricales, and they also differ to some extent from an
ecophysiological point of view.M. rotula (familyMarasmiaceae) is
a fungus that stands betweenwhite rotters and litter decomposers,
because it preferably colonizes small twigs of broad-leaved trees
(Fagus,Quercus, andAcer).C. cinerea (family Psathyrellaceae) nat-
urally dwells on older dung and in soils rich in organic nitrogen
(i.e., it is a specialized litter decomposer).A. aegerita (familyBolbi-
taceae) is a wood-dwelling fungus that causes an unspecific white
rot on trunks and stumps of broad-leaved trees (e.g., Populus and
Acer species). However, it would be daring to conclude from these
evolutionary and ecological differences that the UPOs of these
fungi must be different.
In addition to the experimental assays, where the products
from the reaction of a variety of steroids with the three above-
mentioned peroxygenases were analyzed by gas chromatography-
mass spectrometry (GC-MS), a set of representative molecules
was selected for computational simulations with AaeUPO (for
which a crystal structure is available) to get further insights into
the molecular determinants that affect the reactivity of the differ-
ent steroid types. All simulations followed an identical protocol
where, after appropriate preparation of the protein with heme as
compound I [the two-electron oxidized cofactor containing an
Fe(IV)O porphyrin cation radical complex], each substrate was
placed at the entrance of the heme access channel, still in the
solvent. From there the substrate explored both the entrance path-
way and the active site using Protein Energy Landscape Explora-
tion (PELE) software (19, 20). From the information provided by
the energy profiles and trajectories, analyses of the effect of the
structural differences between the substrates and their peroxyge-
nase reactivity could be rationalized.
MATERIALS AND METHODS
Enzymes. rCciUPO was provided by Novozymes A/S (Bagsvaerd, Den-
mark). This recombinant enzyme corresponds to the protein model 7249
from the sequenced C. cinerea genome, available at the JGI (http:
//genome.jgi.doe.gov/Copci1), expressed in Aspergillus oryzae (40). The
protein was purified using a combination of S-sepharose and SP-sephar-
ose ion-exchange chromatography. The recombinant peroxygenase prep-
aration is an electrophoretically homogeneous glycoproteinwith amolec-
ular mass of around 44 kDa (a nonuniform glycosylation pattern was
observed), a typical UV-visible (UV-Vis) spectrum with a Soret band at
418 nm, and the ability to oxygenate different aromatic compounds with
a specific activity of approximately 100 U · mg1 (measured as described
below).
The AaeUPO andMroUPO enzymes are two wild-type peroxygenases
isolated from cultures of A. aegerita DSM 22459 and M. rotula DSM
25031, deposited at the German Collection of Microorganisms and Cell
Cultures (Braunschweig, Germany). AaeUPO was produced in suspen-
sions of soybean meal and purified by several steps of fast protein liquid
chromatography (FPLC) using different ion exchangers (SP-sepharose,
MonoQ, andMonoS) with size exclusion chromatography (Superdex 75)
as the final isolation step. The final protein fraction had a molecular mass
of 46 kDa with one enriched isoform (AaeUPO II). This isoformwas used
in the present study (7, 21). MroUPO was purified by FPLC to apparent
homogeneity, confirmed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) under denaturing conditions, and showed a
molecular mass of 32 kDa and an isoelectric point of pH 5.0 to 5.3. The
UV-visible spectra of the enzymes showed a characteristic maximum
around 420 nm (Soret band of heme-thiolate proteins) (14).
All media and columns used for enzyme isolation were purchased
fromGEHealthcare Life Sciences. One UPO activity unit is defined as the
amount of enzyme oxidizing 1mol of veratryl alcohol to veratraldehyde
(ε310, 9,300 M
1 · cm1) in 1 min at 24°C, pH 7 (the optimum for per-
oxygenase activity), after addition of H2O2 (0.5 mM H2O2 in rCciUPO
reaction mixtures and 2.5 mM H2O2 in AaeUPO and MroUPO reaction
mixtures).
Steroids. The model steroid compounds (from Sigma-Aldrich) used
in the enzymatic reactions include (i) free sterols, such as cholesterol,
campesterol, ergosterol, sitosterol, and stigmasterol; (ii) steroid ketones,
such as cholestan-3-one, 4-cholesten-3-one, cholesta-3,5-dien-7-one,
and testosterone; (iii) steroid hydrocarbons, such as cholestane, cholesta-
3,5-diene, and pregnane; and (iv) sterol esters, such as cholesteryl acetate,
cholesteryl butyrate, and cholesteryl caprylate (see Fig. 1).
Enzymatic reactions. Reactions of the model steroids (0.05 mM
concentration) with the three peroxygenases (1 U) were performed in
5-ml vials containing 50 mM sodium phosphate (pH 7 in AaeUPO and
rCciUPO reactions and pH 5.5 in MroUPO reactions) at 40°C and a
60-min reaction time in the presence of H2O2 (0.5 mM in rCciUPO
reactions and 2.5 mM in AaeUPO and MroUPO reactions). Prior to
use, the substrates were dissolved in acetone and added to the buffer to
give a final acetone concentration of 40% (vol/vol) in most cases. In
control experiments, substrates were treated under the same condi-
tions (including 0.5 mM and 2.5 mM H2O2) but without enzyme.
Products were recovered by liquid-liquid extraction with methyl tert-
butyl ether and dried under N2. N,O-Bis(trimethylsilyl)trifluoroacet-
amide (Supelco) was used to prepare trimethylsilyl (TMS) derivatives
that were analyzed by GC-MS.
GC-MS analyses. The GC-MS analyses were performed with a Varian
3800 chromatograph coupled to an ion-trap detector (Varian 4000) using
a medium-length fused-silica DB-5HT capillary column (12 m by 0.25
mm internal diameter, 0.1 m film thickness) from J&W Scientific (22).
The oven was heated from 120°C (1 min) to 300°C (15 min) at 10°C ·
min1. The injector was programmed from 60°C (0.1 min) to 300°C (28
min) at 200°C · min1. The transfer line was kept at 300°C, and helium
was used as the carrier gas (2 ml · min1). For some analyses, a Shimadzu
GC-MSQP2010Ultra with a fused-silicaDB-5HT capillary column (30m
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by 0.25 mm internal diameter, 0.1 m film thickness) also was used. The
oven was heated from 120°C (1 min) to 300°C (15 min) at 5°C · min1.
The injection was performed at 300°C, and the transfer line was kept at
300°C. Compounds were identified by mass fragmentography and com-
paring their mass spectra with those of the Wiley and NIST libraries and
standards. Quantification was obtained from total-ion peak area, using
response factors of the same or similar compounds. Data from replicates
were averaged, and in all cases (substrate conversion and relative abun-
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FIG 1 Chemical structures of the different steroid compounds tested as substrates of the peroxygenases, including (i) free sterols, such as cholesterol (A),
campesterol (B), ergosterol (C), sitosterol (D), and stigmasterol (E); (ii) steroid ketones, such as cholestan-3-one (F), 4-cholesten-3-one (G), cholesta-3,5-dien-
7-one (H), and testosterone (I); (iii) steroid hydrocarbons, such as cholestane (J), cholesta-3,5-diene (K), and pregnane (L); and (iv) sterol esters, such as
cholesteryl acetate (M), cholesteryl butyrate (N), and cholesteryl caprylate (O).
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dance of reaction products) the standard deviations were below 3.5% of
the mean values.
PELE computational analyses. For the computational study, eight
representative compounds (cholesterol, sitosterol, cholestan-3-one,
cholesta-3,5-dien-7-one, cholestane, cholesta-3,5-diene, cholesteryl ace-
tate, and cholesteryl caprylate) were prepared and PELE simulations per-
formed.
The starting structure for all PELE simulations was the AaeUPO 2.19-
Å-resolution crystal (PDB entry 2YOR) (23). As the optimum pH for
peroxygenase activity is 7, the structure was prepared accordingly using
Schrodinger’s Protein Preparation Wizard (24) and H web server
(25). Histidines were -protonated, with the exception of His-82 (ε-pro-
tonated) and His-118 and His-251 (double protonated). All acidic resi-
dues were deprotonated, except Asp-85, which was kept in its protonated
state. The eight ligands studied in this section were optimized with Jaguar
7.8 (Schrödinger, LLC, New York, NY) at the DFT/M06 level with the
6-31G** basis and a PBF implicit solvent in order to obtain their electro-
static potential atomic charges. Finally, the heme site was modeled as
compound I after being fully optimized in the protein environment with
quantum mechanics/molecular mechanics (QM/MM) using QSite 5.7
(Schrödinger).
Once the initial protein structure was prepared, the optimized ligands
were placedmanually in identical positions at the entrance of the protein’s
binding pocket and PELE (20) simulations were performed. PELE is a
Monte Carlo-based algorithm that produces new configurations through
a sequential ligand and protein perturbation, side-chain prediction, and
minimization steps. New configurations then are filtered with a Metrop-
olis acceptance test, where the energy is described with an all-atom OPLS
force field (26) and a surface-generalized Born solvent (27). In this way it
is possible to locate and characterize local and global minima structures
for the most favorable protein-ligand interactions. PELE has been used
successfully in a number of ligand migration studies with both small and
large substrates (28–30). In this work, PELE was set up first to drive the
ligands inside the protein until the center of mass was less than 10 Å from
the compound I oxygen. After that, simulation proceeded by allowing a
free exploration of the enzyme active site by the ligand. The results pre-
sented are based on350 48-h trajectories for each ligand.
RESULTS
The efficiency of three peroxygenases (AaeUPO, MroUPO, and
rCciUPO) hydroxylating 15 steroidal compounds (including free
and esterified sterols, steroid hydrocarbons, and ketones) was ex-
perimentally evaluated, and the reaction products were analyzed
by GC-MS. To rationalize the results obtained with the different
steroid types, substrate diffusion simulations were performed
with PELE (20), providing energy profiles and ligand trajectories,
as described in the final section.
Free sterol reactions. Free C27 (cholesterol), C28 (campesterol
and ergosterol), and C29 (sitosterol and stigmasterol) sterols (Fig.
1A to E, respectively) were tested as UPO substrates (Table 1).
Cholesterol was converted to a larger extent than the other sterols,
although the individual enzymes showed differences in their per-
formance (after 60 min): rCciUPO completely (100%) trans-
formed the substrate, followed by AaeUPO (64%) and MroUPO
(23%). The reaction products of cholesterol were oxygenated de-
rivatives at the C-24, C-25, and C-26/C-27 positions of the side
chain (Fig. 1 depicts atom numbering), with the monohydroxy-
lated C-25 derivative predominating (Table 2). Interestingly, a
strict regioselectivity was observed in the reaction of cholesterol
with rCciUPO, yielding 25-hydroxycholesterol as the sole reaction
product.
The position of the hydroxyl group was determined by the
mass spectra of the TMS derivatives, as found for 25-hydroxycho-
lesterol (see Fig. S1 in the supplemental material). The spectrum
includes the molecular ion (m/z 546) and a characteristic ion at
m/z 131, resulting from C-24–C-25 bond cleavage, together with
additional fragments. Likewise, the spectra of monohydroxylated
derivatives at C-24 and C-26 (not shown) showed, in addition to
the molecular ion at m/z 546, the characteristic fragment at m/z
131, described above, and that at m/z 145 from the C-23–C-24
bond cleavage. In the AaeUPO and MroUPO reactions, further
oxidized compounds (carboxycholesterol) at C-26/C-27 were
identified (with a molecular ion at m/z 560 and the above-de-
scribed characteristic fragment atm/z 145), although they were in
small amounts.
The C28 sterols, especially ergosterol, were transformed to a
lesser extent than cholesterol (Table 1). AaeUPO showed more
reactivity toward campesterol and ergosterol than the other per-
oxygenases. The reaction of ergosterol was strictly regioselective,
with 25-hydroxyergosterol being the only reaction product iden-
tified in all cases (Table 2). The reactionwith campesterol also was
highly regioselective, giving the 25-hydroxyderivative as the main
product, although hydroxylation at C-26 also was observed (espe-
cially in the rCciUPO reaction). Likewise, the three peroxygenases
showed low reactivity with the C29 sterols, and only very low con-
version rates (13%)were attained (Table 1). In the reactionwith
stigmasterol, only the monohydroxylated derivative at C-25 was
observed, whereas with sitosterol, nearly the same amount of 28-
hydroxysitosterol was formed by rCciUPO (and a small amount
by AaeUPO) (Table 2).
Steroid ketone reactions. Cholestan-3-one, 4-cholesten-3-
one, cholesta-3,5-dien-7-one, and testosterone (Fig. 1F to I, re-
spectively) were tested as UPO substrates (Table 1). rCciUPOwas
the most efficient enzyme in transforming steroid ketones except
testosterone, which was not modified by any of the three peroxy-
TABLE 1 Conversion of different types of steroid compounds by the
rCciUPO, AaeUPO, andMroUPO peroxygenases within a 60-min
reaction
Substrate
% substrate transformed by:
rCciUPO AaeUPO MroUPO
Free sterols
Cholesterol 100 64 23
Campesterol 30 47 10
Ergosterol 6 10 7
Sitosterol 6 13 4
Stigmasterol 2 2 5
Steroid ketones
Cholestan-3-one 54 42 12
4-Cholesten-3-one 100 67 14
Cholesta-3,5-dien-7-one 97 57 39
Testosterone 0 0 0
Steroid hydrocarbons
Cholestane 14 3 1
Cholesta-3,5-diene 34 18 23
Pregnane 0 0 37
Sterol esters
Cholesteryl acetate 34 16 5
Cholesteryl butyrate 7 1 1
Cholesteryl caprylate 0 0 0
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genases, followed by AaeUPO and MroUPO. The unsaturated
4-cholesten-3-one and cholesta-3,5-dien-7-one were completely
transformed by rCciUPO, and the saturated cholestan-3-one also
was significantly transformed (54%).
The three ketones were predominantly monohydroxylated at
C-25 (Table 3). In the case of cholestan-3-one, the regioselectivity
was strict, since only the 25-monohydroxylated derivative was
formed by the three enzymes, and the same was observed in the
reactions of 4-cholesten-3-one with rCciUPO and MroUPO.
However, in the reaction with AaeUPO, monohydroxylation at
the 4-cholesten-3-one terminal positions (C-26/C-27) also was
observed, although as a minor proportion. Interestingly, in the
reaction of the diunsaturated cholesta-3,5-dien-7-one, hydroxy-
lation in the steroidal ring also was produced, being especially
pronounced in theMroUPO reaction.
Themass spectra of the TMS derivatives of the three 25-mono-
hydroxylated ketones (not shown) showed the above-described
characteristic fragment atm/z 131 (from C-24–C-25 bond cleav-
age). No molecular ions for the saturated and monounsaturated
ketones were observed, although the molecular masses could be
determined from the [M-15] fragments (atm/z 459 andm/z 457,
respectively). However, the mass spectrum of the 25-hydroxy-
derivative of the diunsaturated ketone showed a molecular ion
(m/z 470) in addition to the m/z 131 and [M-15] fragments.
Likewise, the 26-hydroxyderivative of 4-cholesten-3-one showed
amolecular ion (m/z 472) in addition to them/z 131 and [M-15]
fragments. The diunsaturated cholesta-3,5-dien-7-one yielded the
mono- and dihydroxyderivatives, with one hydroxylation at the
steroidal ring. The most prominent fragment in the mass spec-
trum of the monohydroxylated derivative (see Fig. S2A in the
supplemental material) corresponded to the molecular ion atm/z
470. Other characteristic fragments were observed, but the posi-
tion of the hydroxyl group in the ring could not be determined.
Themass spectrum of the dihydroxylated derivative (see Fig. S2B)
showed the characteristic fragment at m/z 131. Additionally, a
molecular ion (m/z 558) and other characteristic fragments were
found, but, like in the monohydroxylated derivative, the position
of the hydroxyl group in the ring could not be determined.
Steroid hydrocarbon reactions. Cholestane, cholesta-3,5-
diene, and pregnane (Fig. 1J to L, respectively) were tested as UPO
substrates (Table 1). Cholestane, and especially cholesta-3,5-
diene, were transformed by the three peroxygenases, with rCci-
UPObeing themost efficient one. In contrast, pregnanewasmod-
ified only byMroUPO.
The reaction products of these hydrocarbons are shown in Ta-
ble 4. Whereas the reaction of cholestane was 100% regioselective
at C-25, cholesta-3,5-diene gave several di- and trihydroxylated
derivatives at the steroidal ring, in addition to the 25-hydroxy-
derivatives (mainly formed by rCciUPO). Among the dihydroxy-
lated derivatives at the ring core, the ones with hydroxylation at
C-3 and C-6 are noteworthy (Fig. 2A and B). In these reactions,
the saturation of one double bond and displacement of the other
one (to C-4) took place. Therefore, the 3,5-diene structure in the
substrate was transformed into a 3,6-dihydroxy-4-ene structure.
Likewise, the C-3 andC-4 dihydroxylated derivatives lost the dou-
ble bond at C-3, yielding a 3,4-dihydroxy-5-ene structure. The
reaction of pregnane with MroUPO gave several monohydroxy-
lated derivatives at the steroid ring (97% of reaction products),
together with a further oxidized derivative (3% 3-ketopregnane)
(see Fig. S3 in the supplementalmaterial), although the position of
the hydroxyl group could not be determined.
The mass spectra of the 25-hydroxycholestane and 25-hy-
droxycholesta-3,5-dieneTMSderivatives (not shown) showed the
characteristic fragment at m/z 131, as well as other characteristic
([M-15], [M-90], and [M-90-15]) fragments. Themass spec-
trumof 3,6-dihydroxycholest-4-ene (Fig. 2A), whose formation is
described above, showed a molecular ion (m/z 546) and a base
peak atm/z 403 considered characteristic of the 4-ene-6-hydroxy
structure (31) together with other fragments (including [M-15],
TABLE 2 Abundance of the different oxygenated derivatives identified
by GC-MS in the reactions of free sterols with rCciUPO, AaeUPO, and
MroUPO peroxygenases
Derivative
Abundance (relative %) of derivative with:
24-OH 25-OH 26/27-OH 28-OH 26/27-COOH
Cholesterol
rCciUPO 100
AaeUPO 6 80 9 5
MroUPO 89 6 5
Campesterol
rCciUPO 85 15
AaeUPO 99 1
MroUPO 98 2
Ergosterol
rCciUPO 100
AaeUPO 100
MroUPO 100
Sitosterol
rCciUPO 52 48
AaeUPO 94 6
MroUPO 100
Stigmasterol
rCciUPO 100
AaeUPO 100
MroUPO 100
TABLE 3 Abundance of the different oxygenated derivatives identified
by GC-MS in the reactions of steroid ketones with rCciUPO, AaeUPO,
andMroUPO peroxygenases
Derivative
Abundance (relative %) of derivative with:
25-OH 26/27-OH x-OH x,25-diOH
Cholestan-3-one
rCciUPO 100
AaeUPO 100
MroUPO 100
4-Cholesten-3-one
rCciUPO 100
AaeUPO 93 7
MroUPO 100
Cholesta-3,5-dien-7-one
rCciUPO 93 7
AaeUPO 87 5 4 4
MroUPO 56 39 5
Babot et al.
4134 aem.asm.org June 2015 Volume 81 Number 12Applied and Environmental Microbiology
 o
n
 M
ay 22, 2015 by Red de Bibliotecas del CSIC
http://aem
.asm
.org/
D
ow
nloaded from
 
[M-90], and [M-15-90]). The mass spectrum of 3,6,25-trihy-
droxycholest-4-ene (Fig. 2B) showed a molecular ion (m/z 634)
and the characteristic fragment atm/z 131, together with the three
additional fragments mentioned above. The mass spectrum of
3,4-dihydroxycholest-4-ene (Fig. 2C) showed a molecular ion
(m/z 546) and the characteristic fragment at m/z 327, together
with other fragments (three additional fragments mentioned
above plus [M-90-90]). Finally, themass spectrum of x,25-dihy-
droxycholesta-3,5-diene (not shown; where “x” denotes the un-
known position of hydroxylation in the ring) showed a molecular
ion (m/z 544) and the characteristic fragment atm/z 131, together
with other fragments ([M-15] and [M-90]), but the position of
the hydroxyl in the steroid ring could not been determined.
Sterol ester reactions. Cholesteryl acetate, butyrate, and
caprylate (Fig. 1M to O, respectively) were tested as UPO sub-
strates (Table 1). The best results were obtained with rCciUPO
and cholesteryl acetate, reaching a conversion yield of 34%. Cho-
lesteryl caprylate was not modified by any of the three peroxyge-
nases. In the reactions of sterol esters, the 25-hydroxyderivative
was the only product identified. The mass spectra (not shown)
showed the characteristic fragment atm/z 131 andmolecular ions
at m/z 544 and m/z 428 for cholesteryl butyrate and acetate, re-
spectively.
Computational analyses. The molecular structures of eight
representative steroids, and that of the AaeUPO (PDB entry
2YOR) enzyme, were prepared at the optimal pH for peroxyge-
nase reactions. PELE simulations were performed, providing en-
ergy profiles and ligand trajectories. The driving criterion for the
simulations was to reduce the distance between the oxygen atom
of the peroxygenase compound I and the center of mass of the
ligand. From the results of the simulations, we computed the frac-
tions of ligand that entered by the C-25 end and the fractions that
entered by the C-3 end. The structures closest to the reactive ox-
ygen then were analyzed as described below. Further detail on
energy profiles and interaction maps for each studied steroid in
the heme active site are available in the supplemental material
(including supplemental computational results and Fig. S4 to S9).
A direct correlation between the percentage of substrate conver-
sion (Table 1) and the percentage of entrance by C-25 was ob-
served (Fig. 3). In the case of cholestane, the fact that it remains 3.6
Å away from the reactive oxygen (see Fig. S7) justifies its reduced
reactivity.
A comparison of PELE simulations (binding energy versus dis-
tance between substrate C-25 and compound I oxygen) for side-
chain hydroxylation of two free sterols and one esterified sterol
(cholesterol, sitosterol, and cholesteryl acetate) is shown in Fig. 4,
which also includes the main interactions in a representative
structure with the ligand at reaction distance from compound I.
Cholesterol has the best fraction (82%) of entrance trajectories
(Fig. 3). The reason for this is a very hydrophobic heme access
channel of peroxygenase, which favors the entrance of the apolar
C-25 side. With the side chain in the active site, the molecule then
is further stabilized by a hydrogen bond with Glu245 on the sur-
face of the protein (Fig. 4A). Reaction at C-24 and C-26/C-27 also
is possible, despite the lower reactivity of secondary and primary
carbons compared to that of tertiary C-25, due to the favorable
minima with these carbons well positioned for reaction (see Fig.
S4 in the supplemental material).
Compared with cholesterol, sitosterol contains an extra ethyl
group. This large substituent impedes the access of the substrate to
the active site, which is reflected by the lower fraction of structures
entering the protein through the C-25 side (39%) compared with
cholesterol (Fig. 3). In particular, at the active site the C-28 and
C-29 groups clash with Ala77 and Thr192 and reduce consider-
ably the number of structures approaching the heme (Fig. 4B). In
addition to C-25, some reaction can be expected at C-28, since the
ligand also approaches a favorable distance for the reaction of this
additional secondary carbon (data not shown). In spite of its sim-
ilar structure, the fraction of cholestan-3-one entrance trajectories
(49%) also is lower than that found for cholesterol (Fig. 3), and the
distance between C-25 and the compound I oxygen is longer (see
Fig. S5 in the supplemental material). This is most probably be-
cause cholestan-3-one is incapable of hydrogen bonding to
Glu245. In the case of cholesta-3,5-dien-7-one, a better approach
TABLE 4 Abundance of the different oxygenated derivatives identified by GC-MS in the reactions of steroid hydrocarbons with rCciUPO, AaeUPO,
andMroUPO peroxygenases
Derivative
Abundance (relative %) of derivative with:
25-OH x-OH x,25-diOH 3,4-diOH-5-en 3,6-diOH-4-en 3,6,25-triOH-4-en
Cholestane
rCciUPO 100
AaeUPO 100
MroUPO 100
Cholesta-3,5-diene
rCciUPO 36 14 3 18a 29
AaeUPO 3 20 35 31b 11
MroUPO 1 36 61c 2
Pregnane
rCciUPO
AaeUPO
MroUPO 100d
a Including 3	,6	-diOH-4-en (14%) and 3
,6
-diOH-4-en (4%).
b Including 3	,6	-diOH-4-en (28%) and 3
,6
-diOH-4-en (3%).
c Including 3	,6	-diOH-4-en (50%) and 3
,6
-diOH-4-en (11%).
d Including 97% hydroxy and 3% keto derivatives (see Fig. S3 in the supplemental material).
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from the ring side, due to the two double bonds present (see Fig.
S6), results in the observed ring hydroxylation.
Cholesteryl acetate has an ester bond at the C-3 hydroxyl, and
as in the case of the ketones described above, binding for C-25
oxidation no longer is favored by the hydrogen bond with Glu245
(Fig. 4C), resulting in lower entrance trajectories (35%) than
those for cholesterol (Fig. 3); however, an approach from the op-
posite side did not result in ring hydroxylation. Cholesteryl capry-
late has a longer acyl chain than the cholesteryl acetate described
above, and (as seen in Fig. S9 in the supplemental material) it does
not approach the heme group from either side (the large hydro-
phobic chains would favor interactions with the protein to avoid
solvent exposure).
Finally, cholesta-3,5-diene has a very interesting reactivity, due
to the presence of two double bonds at C-3 andC-5 and the lack of
the C-3 hydroxyl mentioned above, that resulted in similar en-
trance by both C-25 and C-3 positions (Fig. 5A and B, respec-
tively). This explains the fraction of hydroxylated products at the
steroid rings, with many of them being additions to its double
bonds. In contrast, the bulkier saturated C-5 and C-6 in choles-
tane (and consequent loss of planarity) impedes a suitable binding
of the ligand when it enters by C-25, and a very small number of
structures come close enough to the compound I oxygen (see Fig.
S7 in the supplemental material), explaining the low reactivity of
this compound (cholesterol is converted by 64%,while cholestane
is converted by only 3%) (Fig. 3).
DISCUSSION
Despite significant progress in the development of efficient bio-
catalysts, there is still a great demand for cost-efficient and eco-
nomical biotechnologies to produce valuable steroids. Most work
has been dedicated to steroid modifications catalyzed by whole
microbial cells (1). The present work deals with the oxyfunction-
alization of steroids using fungal peroxygenases, relatively young
representatives of the superfamily of heme-thiolate peroxidases
that are characterized by the presence of a cysteine residue as the
fifth ligand of the heme iron and their peroxygenase activity (8).
Several steroids differing in their structures, including free and
esterified sterols and steroid ketones and hydrocarbons, were
tested as substrates of peroxygenases from three basidiomycete
species. The relationships between the structure of the different
substrates, the enzyme reactivity, and the reaction products ob-
tained are discussed below. A combined experimental and com-
putational approach shows that there is not a unique factor that
determines the hydroxylation profile; instead, it is a result of the
sum of many structural factors, concerning both the steroid mol-
FIG 2 Mass spectra of 3,6-dihydroxycholest-4-ene (A), 3,6,25-trihydroxy-
cholest-4-ene (B), and 3,4-dihydroxycholest-5-ene (C) from peroxygenase re-
actions, with cholesta-3,5-diene (structure K in Fig. 1) as a TMS derivative.
FIG 3 Correlation plot for steroid conversion rate (Table 1) and steroid (side
chain) entrance by C-25 to the enzyme active site. Computational results were
computed from PELE diffusion simulations (20) of eight selected steroids on
the molecular structure of AaeUPO (PDB entry 2YOR). For steroid (A to K)
identification, see the legend to Fig. 1. Cholestane (compound J) has been
removed from the correlation plot (discussed in the text).
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FIG 4 Results fromPELE (20) simulations for cholesterol (A), sitosterol (B), and cholesteryl acetate (C) diffusion at the active site of theAaeUPO, including (left)
plots of the energy profile versus the distance between the steroid H25 and the oxygen atom in enzyme compound I and (right) main interactions between the
substrate and the enzyme in a representative structure for each of the three steroids analyzed. The yellow circles identify structural differences relative to the
structure of cholesterol.
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ecule and the enzyme active site. These include the polar/apolar
character of C-3/C-7 ring groups, the presence of double bonds in
the steroidal rings, and the length and character of the alkyl C-17
chain, which affect the ligand entrance ratio on the C-25 side.
Relationships between steroid structure and conversion
yield. The influence of the C-17 alkyl chain, oxidation/unsatura-
tion of the rings, and esterification of the C-3 hydroxyl group on
the steroid conversions is discussed below.
(i) Alkyl chain at C-17. The influence of the steroid alkyl side
chain substitution and unsaturation was shown by the different
extents of transformation obtained for C27, C28, and C29 sterols.
The C27 cholesterol was completely transformed by rCciUPO,
while the other sterols were transformed to a lesser extent by this
and the two other peroxygenases. The presence of a methyl or
ethyl group at C-24 makes it progressively more difficult to hy-
droxylate campesterol and sitosterol, as illustrated in Fig. 6.More-
over, the double bond at C-22, in addition to the methyl or ethyl
group at C-24, made ergosterol and stigmasterol more difficult to
be hydroxylated (by the three peroxygenases) than the above-de-
scribed campesterol and sitosterol. The influence of a shorter side
chain was shown by comparing the hydroxylation of pregnane
(with an ethyl group at C-17) and other steroid hydrocarbons
(e.g., cholestane). The presence of a two-carbon (instead of eight-
carbon) alkyl chain prevents hydroxylation by rCciUPO and Aae-
UPO and, in contrast, promotes hydroxylation by MroUPO,
which takes place in the steroidal ring (not in the side chain).
Finally, the absence of an alkyl chain at C-17, like in testosterone
(having instead a hydroxyl group), completely prevents its hy-
droxylation by the three fungal peroxygenases (compared with up
to 100% conversion of 4-cholesten-3-one).
The good conversion produced in the reactions of peroxyge-
nases with cholesterol and the differences observed in the conver-
sion of sterols with different alkyl chain sizes, like sitosterol, are
explained by computational results. In general terms, the polarity
of the substituent group at C-3 has a positive correlation with the
ligand rate entrance by the C-25 side. This is due to the hydropho-
bic character of the protein access channel to the heme that con-
tains numerous phenylalanine residues. Moreover, the presence
of a hydroxyl group in C-3 (of cholesterol and other sterols) in-
creases the ligand rate entrance by the C-25 side and stabilizes the
ligand in a suitable catalytic position (a good catalytic position is
assumedwhen the distance between the hydrogen in C-25 and the
compound I oxygen is around 2.4 Å) due to a hydrogen bondwith
Glu245. These two factors correlate perfectly with the high activity
shown for cholesterol. However, although sitosterol also has a
hydroxyl group in C-3, it is not able to access the heme site by the
C-25 end in the same way as cholesterol due to the bulkier alkyl
chain inC-17 that clasheswith residues in the heme access channel
(namely, Thr192, Ala77, Phe69, Phe121, and Phe199).
(ii) Oxidation/unsaturation degree of the rings. Steroids dif-
fering in the oxidation state of the ring were tested, including
steroid hydrocarbons, sterols, and steroid ketones. Whereas rCci-
UPO completely converted both cholesterol and 4-cholesten-3-
one, AaeUPO and MroUPO oxidized the ketone with lower effi-
ciency. The contrary was reported for P450s (e.g., CYP27A1),
which hydroxylated steroids with a 3-oxo-4 structure at a much
higher rate than those with a 3
-hydroxy-5 structure (32).
Therefore, the structural differences between 4-cholesten-3-one
and cholesterol, which are the planarity of the sterol A-ring and
the electronic properties resulting from a keto versus hydroxyl
substituent at C-3, seemingly affect the peroxygenase activity. The
computational results revealed that the polar character of the hy-
droxyl and oxo groups in the sterols and steroid ketones affects in
a positive way the ligand entrance rate by C-25, which correlates
with the high activity that these compounds show compared with
the corresponding steroid hydrocarbons.
On the other hand, although differences were observed be-
tween the three peroxygenases, the presence and number of dou-
ble bonds in the rings of steroid hydrocarbons and ketones signif-
icantly increases their hydroxylation degree. This is illustrated in
Fig. 7, where betterAaeUPO conversion of cholesta-3,5-diene and
cholesta-3,5-dien-7-one, compared with that of the correspond-
ing saturated molecules (cholestane and cholestan-3-one), is
shown. The C-25 side entrance and the placement of the steroid
hydrocarbons in a proper catalytic position are determined by the
presence or absence of double bonds. These reduce the volume of
the steroid ring, facilitating its entrance in the active site, and
provide proper curvature to the substrate for an optimal approach
FIG 5 Results from PELE (20) simulations for cholesta-3,5-diene diffusion at the active site with C-25 (A) or C-3 (B) approaching the heme cofactor of the
AaeUPO.
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to the heme. Therefore, both the apolar nature of the two extremes
of the molecule and the presence of double bonds in cholesta-3,5-
diene facilitate access to the heme from both sides, C-3 and C-25,
and its correct placement for reaction. However, neither the sub-
strate entrance nor its placement in the active site are as suitable as
they are in sterols and steroid ketones. In the case of cholestane,
the entrance to the heme site is hampered by the larger sp3 groups
at C-3, C-4, C-6, and C-7. This can be better observed by compar-
ing the energy profiles of this compound (see Fig. S7 in the sup-
plemental material) to those of cholesta-3,5-diene (see Fig. S8)
and observing the very different occupation of the binding site. In
addition, the higher reactivity of alkenes than alkanes leads to
addition of hydroxyl groups to the double bonds in the steroidal
rings in cholesta-3,5-diene, which is not observed in cholestane.
Concerning the two ketones compared in Fig. 7C andD, although
both have a similar ratio for C-25 entrance, cholestan-3-one can
be hydroxylated at only C-25, while cholesta-3,5-dien-7-one
shows some additional hydroxylation due to the higher reactivity
of the alkenes mentioned above. Moreover, as in the case of the
steroid hydrocarbons, the two double bonds in the steroid ketone
ring will facilitate the entrance and proper positioning of the sub-
strate at the peroxygenase active site.
Due to the above-described effects, although the conversion
rates of cholestan-3-one are lower than those of cholesterol (the
best steroid substrate of the basidiomycete peroxygenases), they
are increased by the presence of double bonds in the steroid ring,
and cholestan-3,5-dien-7-one hydroxylation rates are in the same
order of those obtained for cholesterol.
(iii) Esterified hydroxyl group at C-3. With the aim of inves-
tigating whether the hydroxyl group at C-3, in free form, is neces-
sary for maximal peroxygenase activity, three esters of cholesterol
with organic acids of different chain lengths were assayed as sub-
strates. The experimental results revealed that the presence of an
esterifying group hampers substrate conversion, and that this ef-
fect is directly correlated with increasing chain length of the fatty
acid. In sterol esters, hydroxylation (at C-25) only of the side chain
of the sterol was observed and not at the acyl moiety, despite
AaeUPOand rCciUPObeing found to efficiently hydroxylate fatty
acids (11, 18).
The computational analyses revealed that in the sterol esters,
the C-25 entrance rate is decreased with respect to cholesterol due
to the presence of hydrophobic alkyl chains at the ester site. In the
case of cholesteryl caprylate, which is not transformed by any of
the peroxygenases, the long unsubstituted hydrocarbon chain
tends to “anchor” the substrate away from the heme site by inter-
acting with different groups on the protein surface. Since both
ends are hydrophobic, interactions with the protein minimize the
solvent exposure but restrain the ligand from reaching the heme,
which explains the lack of activity for this compound.
Relationshipsbetween steroid structure and regioselectivity.
In general, the reactions of the three fungal peroxygenaseswith the
different steroids proceed with remarkable regioselectivity and re-
sult in the formation of the 25-hydroxyderivatives as the main
products. The complete conversion of cholesterol by rCciUPO to
produce 25-hydroxycholesterol is noteworthy, since this com-
pound is widely used, displaying an array of pharmacological ac-
tions in vitro and in cell-based systems (33), as discussed below.
Different alkyl chains at C-17 seemingly do not influence the re-
gioselectivity in AaeUPO andMroUPO reactions (see below) but
affect that of rCciUPO, since cholesterol is C-25 hydroxylatedwith
a strict (100%) regioselectivity, whereas for campesterol and sitos-
terol, hydroxylation at terminal C-26/C-27 (15%) and subtermi-
nal C-28 (48%), respectively, also was observed. On the other
hand, the double bond at C-22 in ergosterol and stigmasterol
seemingly influences the strict regioselectivity of the hydroxyla-
tion at C-25. Minor hydroxylation at the terminal positions of the
steroid branched side chain byAaeUPOandMroUPOalso leads in
some cases (e.g., cholesterol) to formation of the C-26/C-27-car-
boxylated derivatives, in addition to the C-26/C-27-hydroxylated
ones. This is because of the further oxidation (successive hydroxy-
lation and dehydration reactions) of themonohydroxylated prod-
FIG 6 GC-MS analysis of the rCciUPO reaction (at 60 min) with cholesterol
(A), campesterol (B), and sitosterol (C) (depicted in Fig. 1) showing the re-
maining substrates and the monohydroxylated derivatives at C-25, C-26, and
C-28 of the side chain.
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ucts, as previously demonstrated in 18O-labeling oxygenation
studies with AaeUPO and H2
18O2 (11).
Hydroxylation at positions other thanC-25 occurs in cases that
show a high (energetically favorable) occupation of binding posi-
tions near any of these centers, as demonstrated for AaeUPO by
computational studies. In particular, the case of cholesterol hy-
droxylation at C-24 is due to interactions between the substrate
and the protein that include a local minima for C-24, which is
slightly more favorable than that for C-25. Hydroxylation at C-25
(tertiary C-H bond) is electronically preferred by its lower C-H
bond strength compared with that of the secondary and primary
C-H bonds (34). In contrast, steric constraints rather than the
differential electronic properties of the C-H bonds have been re-
ported to govern the regioselectivity of the reaction of steroids
(cholesterol and 4-cholesten-3-one) with P450s (CYP125A1)
where terminal oxidation was preferred (35).
Interestingly, in addition to hydroxylation at the side chain,
somehydroxylated derivatives at the steroid core are formedwhen
oxygen groups are lacking at C-3, such as in cholesta-3,5-dione,
cholesta-3,5-diene, or pregnane. Indeed, the presence of a hy-
droxyl or oxo group at this position seems to prevent the hydroxy-
lation of the steroidal core. On the other hand, the presence of two
conjugated double bonds in the ring seems to favor the hydroxy-
lation at the steroidal core, especially byAaeUPOandMroUPO, as
evidenced in the reaction of cholesta-3,5-diene yielding 3,6-dihy-
droxycholest-4-ene and 3,4-dihydroxycholest-5-ene, as men-
tioned above. Themechanism of this double (at C-3 and C-6 or at
C-3 andC-4) hydroxylation implies the displacement of one of the
cholesta-3,5-diene double bonds to the intermediate (C-4 or C-5)
position and the saturation of the other.
Significance of side-chain versus ring hydroxylation. It has
been shown that the reactions of the peroxygenases from the three
different basidiomycetes occurred generally with noteworthy re-
gioselectivity, and hydroxylation at the side chain over the steroi-
dal ring was preferred, with the 25-hydroxyderivatives predomi-
nating. From a biochemical point of view, side-chain and steroid
nucleus oxidation have been confirmed to be independent pro-
cesses, at least in some microorganisms (1). Side-chain hydroxy-
lation is usually a prestep in side-chain degradation in most
microbial systems that oxidize steroids. The initial step of the
side-chain oxidation of sterols (and other C27 steroids) is hy-
droxylation at C-26 or C-27, followed by a complex sequence of
reactions involving different enzymes (some of them still uniden-
tified) that produce the elimination of side chain at C-17 and then
steroidal nucleus oxidation. However, further oxidative degrada-
tion on the C-17 side chain may not occur when hydroxylation is
FIG 7 GC-MS analysis of the rCciUPO reaction (at 60min) with cholestane (A), cholesta-3,5-diene (B), cholestan-3-one (C), and cholesta-3,5-diene-7-one (D)
(depicted in Fig. 1) showing the remaining substrates and the mono-, di-, and trihydroxylated derivatives included in Table 4 (x denotes the unknown position
of hydroxylation in the ring).
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produced at C-25 (instead of C-26 or C-27). This has been ob-
served using 25-hydroxylated cholesterol as the substrate (36),
concluding that C-25 hydroxylation must be a distinct reaction
from that of the usual cholesterol side chain degradation pathway.
Indeed, the authors do not consider that steroid metabolism is a
specific function of UPOs, not as much as it is the oxidation of
alkanes, alkenes, ethers, or aromatics. Rather, UPOs represent a
catalytic system (“extracellular liver”) that, irrespective of a par-
ticular structure, can nonspecifically oxidize diverse compounds
emerging in the fungus microenvironment. In this context, un-
specific detoxification surely is more important than specific deg-
radation.
Interestingly, a previously unrecognized biological (antiviral)
role for 25-hydroxycholesterol, which is selectively formed by the
rCciUPO as discussed above, has been highlighted recently (37).
Indeed, that study revealed 25-hydroxycholesterol as the only ox-
ysterol notably upregulated following macrophage infection or
activation by interferons. This antiviral effect is specific to 25-
hydroxycholesterol, because other related (enzymatically gener-
ated) oxysterols, such as 19-hydroxychoesterol and 7	-hydroxy-
cholesterol, fail to repress viral infection. 25-Hydroxycholesterol
has been reported to have a high potency to inhibit a broad spec-
trum of viruses from high to low physiological concentrations
depending on lipid conditions and virus-host cell system. Like-
wise, other recent studies also revealed 25-hydroxycholesterol as a
potential antiviral therapeutic (38). Independent of its known reg-
ulatory effect onmetabolism, 25-hydroxycholesterol impairs viral
entry at the virus-cell fusion step by inducing cellular membrane
changes. Because 25-hydroxycholesterol can permeate through
membranes, it likely modifies cellular membranes to exert its
antiviral effect. Moreover, in addition to interfering with viral
entry and replication, 25-hydroxycholesterol also amplifies the
activation of immune cells and increases the production of im-
mune mediators (39).
Final remarks. The first crystal structure of a fungal peroxyge-
nase (23), from the basidiomyceteA. aegerita (AaeUPO), was used
in the computational simulations included in the present study.
The availability ofmore peroxygenase crystal structures, including
those from C. cinerea andM. rotula, will provide the opportunity
to correlate the different regioselectivities in steroid oxygenation
described here with the architecture of the active site and other
structural features. Such information will permit us to engineer
these self-sufficient monooxygenases (whose activation depends
on a peroxide source) as new and robust industrial biocatalysts for
the pharmaceutical and fine-chemical sectors.
In conclusion, in the present work, the ability of three different
fungal peroxygenases to catalyze the regioselective hydroxylation
of a variety of steroids is shown for the first time. Generally, hy-
droxylation at the side chain over the steroid ring was preferred,
with 25-hydroxyderivatives being the main products formed. It
has been observed that some structural features of the steroid sub-
strates, such as the presence and length of the alkyl chain at C-17
and the presence of oxygen groups and/or conjugated double
bonds in the steroid ring system, influence substrate conversion
and guide the regioselectivity of the reactions. A better under-
standing of the mechanistic aspects of hydroxylation in combina-
tion with the development of suitable biocatalysts would be the
basis for efficient steroid hydroxylation bioprocesses using new
enzymes with self-sufficient mono(per)oxygenase activities.
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The Supplemental Material include Supplemental Computational Results, and Supplemental 
Figures showing mass spectrum of 25-hydroxycholesterol (Fig. S1), mass spectra of x-
hydroxycholesta-3,5-dien-7-one and 25,x-dihydroxycholesta-3,5-dien-7-one (Fig. S2), and 
chromatogram of the pregnane reaction (Fig. S3); together with PELE simulations for 
cholesterol (Fig. S4), cholestan-3-one (Fig. S5), cholesta-3,5-dien-7-one (Fig. S6), cholestane 
(Fig. S7), cholesta-3,4-diene (Fig. S8) and cholesteryl caprylate (Fig. S9). 
 
 
Supplemental Computational Results 
 
Free and esterified sterols 
Cholesterol (compound A in Fig. 1) has the best fraction of trajectories entering by the C25 
side (82%) (Fig. 3). The reason for this is a hydrophobic entrance to the heme side which 
favors the entrance by the apolar side of the ligand. Then in the active site the molecule is 
further stabilized by a hydrogen bond with Glu245 on the surface of the protein (Fig. 4A). 
Reactions at C24 (Fig. S4A) and C26/C27 (Fig. S4C and D) are possible despite the less 
favorable breaking of secondary and primary C-H bonds due to the presence of minima with 
these hydrogens well positioned for reaction with compound I. In particular C24 approaches 
the heme with a more favorable interaction energy than C25. 
 Sitosterol (compound D in Fig. 1) contains an extra ethyl group at C24. This large 
substituent impedes the entrance of the substrate in the active site, which is reflected by the 
lower fraction of structures entering the protein through C25 side (39% opposed to 82% for 
compound A) (Fig. 3). In particular, at the active site the C28 and C29 groups clash with 
Ala77 and Thr192 which reduces considerably the number of structures capable of 
approaching the heme at a reactive distance (Fig. 4B). Some reaction can nevertheless be 
expected at C28 due to the fact that simulations show that the ligand approaches the heme to a 
favorable distance for reaction at this secondary carbon.  
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Steroid ketones 
Cholestan-3-one (compound F in Fig. 1) has a ketone in C3 instead of an alcohol and a single 
bond between C5 and C6. This ligand is not able to enter the binding pocket as well as 
compound A (Fig. S5). First the fraction of entrances by the C25 side is reduced (from 82% 
to 49%) and second the distance between the reactive hydrogen and the oxygen atom in 
cholestan-3-one is slightly longer (2.5 Å in A to 2.8 Å in F). This will have an effect in the 
reactivity of the compound and in particular will favor reaction at the most labile hydrogen 
(H25 being tertiary) since the number of reactive positions is considerably reduced (when 
compared to cholesterol). Interaction of the ligand in the active site is less favorable than  
cholesterol due to the fact that cholestan-3-one is incapable of hydrogen bonding to Glu245. 
 Cholesta-3,5-dien-7-one (compound H in Fig. 1) does not have the alcohol in C3, instead it 
has a ketone in C7 and an extra double bond at C3-C4. This molecule has an identical activity 
as cholesterol (57% substrate conversion vs. 64). Here the entrance by the C25 side is reduced 
(from 82% in cholesterol to 58% in cholesta-3,5-dien-7-one) probably due to the apolar nature 
of the steroid ring on the external side (C3) (Fig. S6). This also justifies reaction observed in 
the ring due to the presence of the double bond and C3 which can place itself correctly in the 
active site. However the hydrogen present on a carbon atom with an sp
2
 hybridization has 
lower reactivity (similar to a primary carbon) which can explain the low percentage of 
product at the steroid ring. 
 
Steroid hydrocarbons 
Cholestane (compound J in Fig. 1) lacks the polar alcohol group in C3, which increases the 
fraction of entrance by this side of the ligand, but most importantly the bulkier saturated C5 
and C6 (and consequent loss of planarity) impedes a suitable placement of the ligand in the 
binding site when it enters by C25. For this reason a low number of structures come close 
enough to the oxygen atom in cholestane (Fig. S7) which explains the low reactivity of this 
compound (cholesterol is converted by 64% while only 3% for cholestane). 
 Cholesta-3,5-diene (compound K in Fig. 1) has a very interesting reactivity due to the 
presence of two double bonds at C3 and C5. Also the lack of any polar group leads to a less 
favorable entrance by C25 (82% for A and 45% for K) (Fig. 3). This compound should also 
be compared to cholesta-3,5-dien-7-one as they only differ by the presence of a ketone group 
at C7 (Figs. S6 and S8). This group has a considerable effect in reactivity. First it decreases 
the fraction of entrances by C3 (55% for K vs. 42% for H), thus increasing the conversion of 
the reactants to products (18% for K 57% and for H). Second, the more favorable entrance by 
C3 for cholesta-3,5-diene increases the fraction of hydroxylated products at the steroid rings. 
It is also interesting to note that many of these products are additions to the double bond. 
 
Sterol esters 
Cholesteryl acetate (compound M in Fig. 1) has almost the same structure as cholesterol but 
with an ester instead of a hydroxyl group in the C3. For this reason, the entrance to the protein 
by this side (Fig. 3) is favoured compared to cholesterol, while the opposite occurs at the C25 
side (82% for cholesterol and 35% for cholesteryl acetate) (Fig. 3). Moreover, the binding 
position of the ligand in the C25 oxidation is no longer favoured by the hydrogen bond with 
Glu245 (Fig. 4). 
 Cholesteryl caprylate (compound O in Fig. 1) is similar to cholesteryl acetate but with a 
larger alkyl chain in the ester group. PELE simulations show that the ligand does not 
approach the heme group from the C25 side (Fig. S9) nor by the C3 (data not shown). The 
reason for this is the large hydrophobic chains that favor interactions with the protein to avoid 
solvent exposure. An unusual binding mode occurs for this molecule where a strong minimum 
energy structure is observed that hinders the correct placement of the molecule in the active 
site by either end. 
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Supplemental Figures 
 
 
 
 
FIG S1 Mass spectrum of 25-hydroxycholesterol from peroxygenase reactions with 
cholesterol (see Fig. 1), as TMS derivative. 
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FIG S2 Mass spectra of x-hydroxycholesta-3,5-diene-7-one (A) and x,25-dihydroxycholesta-
3,5-diene-7-one (B) from peroxygenase reactions with cholesta-3,5-diene-7-one (see Fig. 1), 
as TMS derivatives. 
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FIG S3 GC-MS analysis of the MroUPO reaction (at 60 min) with pregnane (see Fig. 1) 
showing the remaining substrate and the monohydroxylated derivatives (x denotes the 
unknown position of hydroxylation in the ring).  
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FIG S4 Results from PELE simulations for cholesterol (compound A in Fig. 1). The distances 
plotted correspond to the C24 (A), C25 (B), C26 (C) or C27 (D) atoms to the oxygen atom in 
AaeUPO compound I. 
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FIG S5 Results from PELE simulations for cholestan-3-one (compound F in Fig. 1) diffusion 
at the active site of the AaeUPO including: (left) Plots of the energy profile vs. the distance 
between the steroid H25 and the oxygen atom in enzyme compound I; and (right) Main 
interactions between cholestan-3-one and the enzyme in a representative structure in the 
binding site. The yellow circles identify structural differences relative to cholesterol. 
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FIG S6 Results from PELE simulations for cholesta-3,5-dien-7-one (compound H in Fig. 1) 
diffusion at the active site with C25  approaching the heme cofactor of the AaeUPO, 
including: (left) Plots of the energy profile vs. the distance between the steroid H25 atom and 
the oxygen atom in enzyme compound I; and (right) Main interactions between cholesta-3,5-
dien-7-one and the enzyme in a representative structure in the binding site. The yellow circles 
identify structural differences relative to cholesterol. 
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FIG S7 Results from PELE simulations for cholestane (compound J in Fig. 1) diffusion at the 
active site with C25 approaching the heme cofactor of the AaeUPO, including: (left) Plots of 
the energy profile vs the distance between the steroid C25  atom and the oxygen atom in 
enzyme cholestane; and (right) Main interactions between cholestane and the enzyme in a 
representative structure in the binding site. The yellow circles identify structural differences 
relative to cholesterol. 
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FIG S8 Results from PELE simulations for cholesta-3,4-diene (compound K in Fig. 1) 
diffusion at the active site with C25 approaching the heme cofactor of the AaeUPO, 
including: (left) Plots of the energy profile vs. the distance between the steroid H25 atom and 
the oxygen atom in enzyme compound I; and (right) Main interactions between cholesta-3,4-
diene and the enzyme in a representative structure in the binding. The yellow circles identify 
structural differences relative to cholesterol. 
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FIG S9 Results from PELE simulations for cholesteryl caprylate (compound O in Fig. 1) 
diffusion at the active site with C25 approaching the heme cofactor of the AaeUPO, 
including: (left) Plots of the energy profile vs. the distance between the steroid H25 atom and 
the oxygen atom in enzyme compound I; and (right) Main interactions between cholesteryl 
caprylate and the enzyme in a representative structure in the binding site. The yellow circles 
identify structural differences relative to cholesterol. 
 
 
